Hattori Yutaka 服部豊

… Alternative Names

HATTORI Yutaka 服部豊

服部豊ハツトリユタカ

Less

Researcher Number	20189575
Other IDs
Affiliation (Current)	2025: 国際医療福祉大学, 国際医療福祉大学病院, 非常勤講師
Affiliation (based on the past Project Information) *help	2016 – 2023: 慶應義塾大学, 薬学部(芝共立), 教授 2014 – 2015: 慶應義塾大学, 薬学部, 教授 2009 – 2011: Keio University, 薬学部, 教授 1997 – 1999: 慶應義塾大学, 医学部, 助手 1990: 国立がんセンター, 分子腫瘍部, 研究員
Review Section/Research Field	Principal Investigator Hematology / Basic Section 54010:Hematology and medical oncology-related / Hematology Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Hematology / Medical pharmacy
Keywords	Principal Investigator 上皮間葉系移行 / 多発性骨髄腫 / ハイリスク多発性骨髄腫 / 薬剤耐性 / TC11 / ドラッグリポジショニング / チロシンキナーゼ阻害 / drug resistance / 薬学 / 内科 … More / オートファジー / GTN057 / 免疫組織学的検討 / リプログラミング / 細胞接着仲介薬剤耐性(CAM-DR) / exosome / nucleophosmin (NPM)1 / 天然物 / 上皮間葉転換 / PEG-TC11 / cadherin / 多発生骨髄腫 / G2/M細胞周期停止 / フタル酸 / リプログラミング遺伝子 / gene therapy / hematopoietic stem cell transplantation / thioredoxin / 遺伝子治療 / 造血幹細胞移植 / チオレドキシン / nucleophosmin-1 / 髄外病変 / 免疫調節薬 / TP53 / in vitro virus法 / 骨病変 / In Vitro Virus法 / 骨髄異形成症候群(MDS) / 増殖因子 / 破骨細胞 / サリドマイド … More Except Principal Investigator 多発性骨髄腫 / 膵がん / 免疫増強薬 / 複合免疫療法 / 免疫学的細胞死 / エピジェネティクス / 免疫療法 / T細胞 / 脱メチル化剤 / CTL / がん抗原 / 白血病幹細胞 / GnT-V / シアル酸 / マンノース / バイオマーカー / 糖鎖 / Mタンパク / 急性前骨髄球性白血病 / アポトーシス / 細胞分化 / 脂溶性リガンド / 白血病細胞 / 造血幹細胞 / 情報伝達 / 受容体 / 増殖・分化因子 / サイトカイン / 転写因子 / 転写制御 / 遺伝子発現 Less

Why multiple myeloma is incurable?Exploitation of molecular pathogenesis and development of overcoming drug by targeting autophagyPrincipal Investigator
- Principal Investigator
  
  服部豊
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Keio University
Exploitation of molecular mechanisms and development of overcoming drugs from new perspectives for high-risk myeloma with poor prognosisPrincipal Investigator
- Principal Investigator
  
  Hattori Yutaka
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Keio University
Development of novel combined immunotherapy using in silico screening system
- Principal Investigator
  
  Matsushita Maiko
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Keio University
molecular analysis and drug discovery targeting extramedullary disease in high-risk multiple myelomaPrincipal Investigator
- Principal Investigator
  
  HATTORI Yutaka
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Keio University
Drug discovery based on novel concept for overcoming high-risk myeloma which is still intractable despite of recent progress in the treatmentPrincipal Investigator
- Principal Investigator
  
  Hattori Yutaka
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Keio University
Development of novel immunotherapy targeting leukemic stem cells.
- Principal Investigator
  
  Matsushita Maiko
- Project Period (FY)
  2014 – 2016
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Keio University
M-protein binding oligosaccharides as a candidate of biomarker for multiple myeloma
- Principal Investigator
  
  IIJIMA Shiro
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Bunkyo Gakuin University
Analysis on molecular mechanism of anti-tumor effect of thalidomide and exploitation of novel agents to overcome therapy-resistant multiple myelomaPrincipal Investigator
- Principal Investigator
  
  HATTORI Yutaka
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Keio University
Establishment of Novel Method for Hematopoietic Stem Cell Transplantation Using Thioredoxin-Gene Transfer TechniquePrincipal Investigator
- Principal Investigator
  
  HATTORI Yutaka
- Project Period (FY)
  1998 – 1999
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Hematology
- Research Institution
  Keio University
脂溶性リガンドによる造血調節:新たな体外増幅を目指して
- Principal Investigator
  
  KIZAKI Masahiro
- Project Period (FY)
  1997
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Research Institution
  Keio University
がんの増殖と分化に関連する遺伝子の発現制御
- Principal Investigator
  
  長田重一
- Project Period (FY)
  1990
- Research Category
  
  Grant-in-Aid for Cancer Research
- Research Institution
  Osaka Bioscience Institute

[Book] 薬剤師のための症候学　第2版第6刷2023
- Author(s)
  服部　豊
- Total Pages
  122
- Publisher
  慶應義塾大学出版会
- ISBN
  9784766419283
- Data Source
  KAKENHI-PROJECT-23K07869
[Journal Article] GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c-MET tyrosine kinase.2023
- Author(s)
  Okayama M, Fujimori K, Sato M, Samata K, Kurita K, Sugiyama H, Suto Y, Iwasaki G, Yamada T, Kiuchi F, Ichikawa D, Matsushita M, Hirao M, Kunieda H, Yamazaki K, Hattori Y.
- Journal Title
  
  Cancer Medicine
  
  Volume: - Issue: 8 Pages: 9749-9759
- DOI
  10.1002/cam4.5691
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08763, KAKENHI-PROJECT-23K07869, KAKENHI-PROJECT-22K19387
[Journal Article] Immunomodulatory Effect of Proteasome Inhibitors via the Induction of Immunogenic Cell Death in Myeloma Cells2023
- Author(s)
  Matsushita Maiko、Kashiwazaki Sho、Kamiko Satoshi、Kobori Michio、Osada Makoto、Kunieda Hisako、Hirao Maki、Ichikawa Daiju、Hattori Yutaka
- Journal Title
  
  Pharmaceuticals
  
  Volume: 16 Issue: 10 Pages: 1367-1367
- DOI
  10.3390/ph16101367
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-23K07869
[Journal Article] A thermoresponsive cationic block copolymer brush-grafted silica bead interface for temperature-modulated separation of adipose-derived stem cells2022
- Author(s)
  Kenichi Nagase, Akari Okada, Junnosuke Matsuda, Daiju Ichikawa, Yutaka Hattori, Hideko Kanazawa
- Journal Title
  
  Colloids and Surfaces B: Biointerfaces
  
  Volume: 220 Pages: 112928-112928
- DOI
  10.1016/j.colsurfb.2022.112928
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K19899, KAKENHI-PROJECT-21KK0199, KAKENHI-PROJECT-19H02447, KAKENHI-PROJECT-20K08763, KAKENHI-PUBLICLY-22H04560
[Journal Article] SORT1/LAMP2-mediated extracellular vesicle secretion and cell adhesion are linked to lenalidomide resistance in multiple myeloma2022
- Author(s)
  Yamamoto Tomofumi、Nakayama Jun、Yamamoto Yusuke、Kuroda Masahiko、Hattori Yutaka、Ochiya Takahiro
- Journal Title
  
  Blood Advances
  
  Volume: 6 Issue: 8 Pages: 2480-2495
- DOI
  10.1182/bloodadvances.2021005772
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21H02706, KAKENHI-PROJECT-21H02721, KAKENHI-PROJECT-20K08763
[Journal Article] Negative E-cadherin expression on bone marrow myeloma cell membranes is associated with extramedullary disease.2022
- Author(s)
  Hirao M, Yamazaki K, Watanabe K, Mukai K, Hirose S, Osada M, Tsukada Y, Kunieda H, Denda R, Kikuchi T, Sugimori H, Okamoto S, Hattori Y
- Journal Title
  
  F1000 Research
  
  Volume: - Pages: 245-245
- DOI
  10.12688/f1000research.109551.1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K08763
[Journal Article] Integrin β5 and β7 expression in lenalidomide‐resistant multiple myeloma cells2022
- Author(s)
  Yutaka Hattori, Takumi Futo, Ryo Uozaki, Daiju Ichikawa, Takashi Yamaguchi, Tomofumi Yamamoto, Maiko Matsushita, Maki Hirao
- Journal Title
  
  International Journal of Hematology
  
  Volume: 115 Issue: 4 Pages: 605-608
- DOI
  10.1007/s12185-022-03297-w
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K08763
[Journal Article] A phenylphthalimide derivative, TC11, induces apoptosis by degrading MCL1 in multiple myeloma cells2020
- Author(s)
  Ichikawa Daiju、Nakamura Misa、Murota Wakana、Osawa Sho、Matsushita Maiko、Yanagawa Hiroshi、Hattori Yutaka
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: 521 Issue: 1 Pages: 252-258
- DOI
  10.1016/j.bbrc.2019.10.119
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09940
[Journal Article] A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress.2018
- Author(s)
  1.Okayama M, Kitabatake S, Sato M, Fujimori K, Ichikawa D, Matsushita M, Suto Y, Iwasaki G, Yamada T, Kiuchi F, Hirao M, Kunieda H, Osada M, Okamoto S, Hattori Y.
- Journal Title
  
  Biochem Biophys Res Commun.
  
  Volume: 505 Issue: 3 Pages: 787-793
- DOI
  10.1016/j.bbrc.2018.09.177
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09940, KAKENHI-PROJECT-16H04714
[Journal Article] A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest.2017
- Author(s)
  Aida S, Hozumi M, Ichikawa D, Iida K, Yonemura Y, Tabata N, Yamada T, Matsushita M, Sugai T, Yanagawa H, Hattori Y
- Journal Title
  
  Biochem. Biophysic. Res. Commun.
  
  Volume: 493 Issue: 1 Pages: 514-520
- DOI
  10.1016/j.bbrc.2017.08.159
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09940, KAKENHI-PROJECT-16H04714, KAKENHI-PROJECT-16K19059
[Journal Article] CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients2017
- Author(s)
  Matsushita M, Ozawa K, Suzuki T, Nakamura M, Nakano N, Kanchi S, Ichikawa D, Matsuki E, Sakurai M, Karigane D, Kasahara H, Tsukamoto N, Shimizu T, Mori T, Nakajima H, Okamoto S, Kawakami Y, Hattori Y
- Journal Title
  
  Blood Cancer J.
  
  Volume: 7 Issue: 9 Pages: 601-601
- DOI
  10.1038/bcj.2017.84
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K09909, KAKENHI-PROJECT-17K09940, KAKENHI-PROJECT-26221005, KAKENHI-PROJECT-16J07143
[Journal Article] Synthesis and biological evaluation of the natural product komaroviquinone and related compounds aiming at a potential therapeutic lead compound for high-risk multiple myeloma.2017
- Author(s)
  Suto Y, Sato M, Fujimori K, Kitabatake S, Okayama M, Ichikawa D, Matsushita M, Yamagiwa N, Iwasaki G, Kiuchi F, Hattori Y.
- Journal Title
  
  Bioorganic & Medicinal Chemistry Letters
  
  Volume: 27 Issue: 19 Pages: 4558-4563
- DOI
  10.1016/j.bmcl.2017.08.054
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17K09940, KAKENHI-PROJECT-16K19059
[Journal Article] 分子標的療法サリドマイド　多発性骨髄腫学2016
- Author(s)
  服部　豊
- Journal Title
  
  日本臨床
  
  Volume: 74(5) Pages: 316-320
- Data Source
  KAKENHI-PROJECT-26461432
[Journal Article] A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts.2015
- Author(s)
  Matsushita　M, Yoshie Ozaki Y, Hasegawa Y, Terada F, Tabata N, Shiheido H, Yanagawa H, Oikawa T, Matsuo K, Du W, Yamada T, Hozumi M, Ichikawa D, and Hattori Y.
- Journal Title
  
  PLoS One
  
  Volume: 10(1)
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26461432
[Journal Article] 自家造血幹細胞移植5年後にB細胞性急性リンパ性白血病を発症した多発性骨髄腫2012
- Author(s)
  塚田唯子、服部豊、中島秀明、横山健次、村田満、清水長子、近藤直美、岡本真一郎
- Journal Title
  
  臨床血液
  
  Volume: 53 Pages: 219-223
- NAID
  10030830402
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/22450582
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] 免疫グロブリン異常症多発性骨髄腫を中心に2011
- Author(s)
  服部豊
- Journal Title
  
  日本内科学会雑誌
  
  Volume: 100 Pages: 1773-1780
- NAID
  10029747785
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] Prospective Study of Combination Therapy with Low-Dose Thalidomide plus Prednisolone Ameliorating Cytopenia in Primary Myelofibrosis.2011
- Author(s)
  Hattori Y, ほか7名
- Journal Title
  
  Int J Hematol.
  
  Volume: 93 Pages: 129-131
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis2011
- Author(s)
  Hattori Y, Miyakawa Y, Yokoyama K, Yamada T, Du W, Jinzaki M, Shinmoto H, Okamoto S
- Journal Title
  
  Int J Hematol
  
  Volume: 93 Pages: 129-131
- NAID
  10029532827
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/21153775
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] 免疫グロブリン異常症2011
- Author(s)
  服部豊
- Journal Title
  
  多発性骨髄腫を中心に日本内科学会雑誌
  
  Volume: 100 Pages: 1773-1780
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/21863752
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] Efficacy of Long-Term Treatment with Low-Dose Thalidomide for Patients with Relapsed/Refractory Multiple Myeloma2011
- Author(s)
  Shimizu K, 他19名中服部豊は4番目
- Journal Title
  
  International Journal of Clinical Medicine
  
  Volume: 2 Pages: 570-575
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] 多発性骨髄腫の初期治療、海外からの報告の総括とわが国の現状2010
- Author(s)
  服部豊
- Journal Title
  
  臨床血液
  
  Volume: 51 Pages: 1499-1510
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] 多発性骨髄腫の初期治療2010
- Author(s)
  服部豊
- Journal Title
  
  海外からの報告の総括とわが国の現状臨床血液
  
  Volume: 51 Pages: 1499-1510
- URL
  http://www.ncbi.nlm.nih.gov/pubmed/20962484
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] 多発性骨髄腫とボルテゾミブ2009
- Author(s)
  定平健, 服部豊
- Journal Title
  
  日本医師会雑誌 138(4)
  
  Pages: 734-735
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] Production of a reactive metabolite of troglitazone by electrochemical oxidation performed in nonaqueous medium2009
- Author(s)
  Tahara K, Nishikawa T, Hattori Y, Iijima S, Kouno Y, Abe Y.
- Journal Title
  
  J Pharm Biomed Anal 50
  
  Pages: 1030-1036
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] 多発性骨髄腫とボルテゾミブ2009
- Author(s)
  定平健、服部豊
- Journal Title
  
  日本医師会雑誌
  
  Volume: 138 Pages: 734-5
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article]2009
- Author(s)
  服部豊
- Journal Title
  
  今日の治療指針2009 血液疾患多発性骨髄腫(医学書院)
  
  Pages: 511-513
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] サリドマイドの新たなる適応2009
- Author(s)
  服部豊
- Journal Title
  
  日本病院薬剤師会雑誌 45
  
  Pages: 645-648
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article]2009
- Author(s)
  服部豊
- Journal Title
  
  薬剤師のための症候学(慶應義塾大学出版会)
  
  Pages: 1-86
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] サリドマイドの新たなる適用多発性骨髄腫における作用と安全性2009
- Author(s)
  服部豊
- Journal Title
  
  日本病院薬剤師会雑誌
  
  Volume: 45 Pages: 645-648
- Data Source
  KAKENHI-PROJECT-21591221
[Journal Article] A phthalimide derivative that is effective on multiple myeloma inhibits centrosomal clustering by interacting with nucleophosmin
- Author(s)
  Shiheido H, Terada F, Tabata N, Ichigo Hayakawa I, Matsumura N, Takashima H, Ogawa Y, Du W, Yamada T, Shoji M, Sugai T, Doi N, Iijima S, Hattori Y and Yanagawa H
- Journal Title
  
  PLOS ONE
  
  Volume: (in press)
- Data Source
  KAKENHI-PROJECT-21591221
[Patent] フェニルフタルイミド修飾体及びそれを有効成分とする抗癌剤2016
- Inventor(s)
  服部豊、柳川弘志ほか
- Industrial Property Rights Holder
  服部豊、柳川弘志ほか
- Industrial Property Rights Type
  特許
- Filing Date
  2016-10-21
- Data Source
  KAKENHI-PROJECT-26461432
[Presentation] 多発性骨髄腫に対して免疫原性細胞死を誘導する天然物由来化合物の安全性と有効性の検討2023
- Author(s)
  藤浪太晴、栗田昂希、松下麻衣子、市川大樹、須藤豊、服部豊
- Organizer
  第48回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-23K07869
[Presentation] エピジェネテイック因子CDYL2は多発性骨髄腫におけるレナリドミド感受性を減弱する2023
- Author(s)
  市川大樹、松下麻衣子、服部豊
- Organizer
  第48回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-23K07869
[Presentation] 新たな視点から病態を見つめて、限界の打破を目指した創薬研究2023
- Author(s)
  服部　豊
- Organizer
  第48回日本骨髄腫学会学術集会　会長講演
- Invited
- Data Source
  KAKENHI-PROJECT-23K07869
[Presentation] 多発性骨髄腫における一細胞統合データセットの構築2023
- Author(s)
  山元智史、中山淳、服部豊、落谷孝広、山本雄介
- Organizer
  第48回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-23K07869
[Presentation] Len長期暴露細胞株の樹立とインテグリンβ-5及びインテグリンβ-7の薬剤耐性への関与2022
- Author(s)
  臼井凜、唐崎翼、栗田昂希、杉山裕夢、市川大樹、松下麻衣子、平尾磨樹、服部豊
- Organizer
  第47回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-20K08763
[Presentation] 多発性骨髄腫に対するKU-MEL-9を標的とした免疫療法の開発2022
- Author(s)
  大月萌賀、松下麻衣子、須田ゆきの、斎藤朔、市川大樹、服部豊
- Organizer
  日本薬学会生物系薬学部会主催　第22回Pharmaco-Hematologyシンポジウム
- Data Source
  KAKENHI-PROJECT-20K08763
[Presentation] Development of komaroviquinone-derivatives that induce immune cell death of multiple myeloma.2022
- Author(s)
  Kurita K, Matsushita M, Tamura K, Ichikawa D, Suto Y, Iwasaki G, Hattori Y
- Organizer
  The 84th Annual Meeting of the Japanese Society of Hematology
- Data Source
  KAKENHI-PROJECT-20K08763
[Presentation] 造血器腫瘍に対する治療のstate-of-the-arts　多発性骨髄腫2022
- Author(s)
  服部豊
- Organizer
  日本薬学会生物系薬学部会主催　第22回Pharmaco-Hematologyシンポジウム
- Invited
- Data Source
  KAKENHI-PROJECT-20K08763
[Presentation] Drug repositioning revealed ambroxol induced myeloma cell death by inhibiting autophagy.2022
- Author(s)
  Sugiyama H, Kaneko S, Fujihashi K, Shibata S, Matsumoto Y, IImura N, Endo S, Inoue M, Ichikawa D, Matsushita M, Yamazaki K, Hirao M, Hattori Y.
- Organizer
  The 84th Annual Meeting of the Japanese Society of Hematology
- Data Source
  KAKENHI-PROJECT-20K08763
[Presentation] 髄外病変で高発現するリプログラミング因子がもたらす骨髄腫の病態への寄与2022
- Author(s)
  唐崎翼、小山遼太郎、杉山裕夢、臼井凜、栗田昂希、市川大樹、松下麻衣子、山崎皓平、平尾磨樹、服部豊
- Organizer
  日本薬学会生物系薬学部会主催　第22回Pharmaco-Hematologyシンポジウム
- Data Source
  KAKENHI-PROJECT-20K08763
[Presentation] Effect of Multiple Myeloma Therapeutics on Autophagy Pathway2021
- Author(s)
  Ryo Kaneko, Yutaka Hattori, Maiko Matsusita, Daiju Ichikawa
- Organizer
  80th Annual Meeting of the Japanese Cancer Association
- Data Source
  KAKENHI-PROJECT-20K08763
[Presentation] 骨髄腫細胞においてリプログラミング遺伝子による脱分化が薬剤抵抗性とクローン増殖性を増強する2019
- Author(s)
  辻宏樹、不藤拓海, 佐俣光一, 山元智史, 市川大樹, 松下麻衣子, 服部豊
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] A novel candidate for immunological target in treatment of multiple myeloma.2019
- Author(s)
  Maiko Matsushita, Saku Saito, Kanae Mori, Shinya Yokoe, Daiju Ichikawa, Yutaka Hattori
- Organizer
  An AACR Special Conference on Tumor Immunology and Immunotherapy
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07331
[Presentation] 多発性骨髄腫細胞のレナリドミド耐性に関する多様な分子メカニズム2019
- Author(s)
  不藤拓海、宇於崎凉, 山口高史, 山元智史, 辻宏樹, 佐俣光一, 市川大樹, 松下麻衣子, 服部豊
- Organizer
  第81回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] Characteristics of Cytotoxic T Cells against Myeloma Cells for Adoptive Immunotherapy.2019
- Author(s)
  Saito S, Matsushita M, Mori K, Yokoe S, Ichikawa D, Hattori Y
- Organizer
  10th Intenational symposium of Japanese Society of Hematology.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] Characteristics of Cytotoxic T Cells against Myeloma Cells for Adoptive Immunotherapy.2019
- Author(s)
  Saku Saito, Maiko Matsushita, Kanae Mori, Shinya Yokoe, Daiju Ichikawa, Yutaka Hattori
- Organizer
  第10回日本血液学会国際シンポジウム
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07331
[Presentation] komaroviquinoneという天然物由来の新規化合物がin vivoにおいて抗MM活性を示す2019
- Author(s)
  佐俣光一、岡山幹夫、藤森宏太、山元智史、市川大樹、松下麻衣子、須藤豊、岩崎源司、山田健人、服部豊
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] 天然物由来成分komaroviquinone及びその誘導体群はin vivoにおいて抗骨髄腫活性を示す2019
- Author(s)
  佐俣光一、岡山幹夫、藤森宏太、西山沙織、辻宏樹、不藤拓海、市川大樹、松下麻衣子、岩崎源司、須藤豊、山田健人、平尾磨樹、国枝尚子、長田眞、服部豊
- Organizer
  日本薬学会生物系薬学部会第20回Pharmaco-Hematologyシンポジウム
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] Elucidation of the IMiDs-Resistant Mechanism and Development of the Overcoming Drugs Inducing CRBN Independent G2/M Cell Cycle Arrest in Myeloma Cells.2018
- Author(s)
  Uozaki R, Aida S, Yamagughi T, Yamamoto T, Kashiwazaki S, Yanagawa H, Ichikawa D, Matsushita M and Hattori Y
- Organizer
  60th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. abst 4451 2018/12/03 San Diego CA.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] プロテアソーム阻害薬の免疫原性細胞死による免疫調節機能2018
- Author(s)
  柏崎翔、神子智史、宇於崎涼、山本智史、市川大樹、服部豊、松下麻衣子
- Organizer
  第80回日本血液学会学術集会
- Data Source
  KAKENHI-PROJECT-18K07331
[Presentation] Analysis of immunogenic cell death (ICD) induced in multiple myeloma cells.2018
- Author(s)
  Maiko Matsushita, Sho Kashiwazaki, Satoshi Kamiko, Ryo Uozaki, Tomohumi Yamamoto, Daiju Ichikawa, Yutaka Hattori
- Organizer
  CRI-CIMT-EATI-AACR Fourth International Cancer immunotherapy conference
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07331
[Presentation] 多発性骨髄腫のIMIDs抵抗性メカニズムの解明2018
- Author(s)
  宇於崎涼、市川大樹、松下麻衣子、服部豊
- Organizer
  第77回日本癌学会学術集会大阪国際会議場　大阪市2018/9/27
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] 天然物コマロビキノン及び関連化合物の骨髄腫細胞に対する抗腫瘍活性の評価2018
- Author(s)
  須藤豊、佐藤真梨子、北畠翔太朗, 藤森宏太, 岡山幹夫, 市川大樹, 松下麻衣子, 山際教之, 岩崎源司, 木内文之, 服部豊
- Organizer
  日本薬学会第138年会
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] 新規天然化合物コマロビキノン化合物の抗骨髄腫効果および構造展開2018
- Author(s)
  岡山幹夫、北畠翔太朗、佐藤真梨子、藤森宏太、左俣光一、市川大樹、松下麻衣子、須藤豊、岩崎源司、山田健人、木内文之、岡本真一郎、服部豊
- Organizer
  第80回日本血液学会学術集会大阪国際会議場　大阪市2018/10/14
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] Understanding the Role of Extracellular Vesicles in Lenalidomide-Resistance Multiple Myeloma.2018
- Author(s)
  Yamamoto T, Kosaka N, Ochiya T and Hattori Y
- Organizer
  60th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition. abst 1887 2018/12/01 San Diego CA.
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] PEG(E)-TC11, a novel polyehylene glycol-linked phthalimide derivative, inhibited high-risk MM cell growth in vivo and in vitro via cell cycle G2/M arrest in a CRBN-independent manner.2017
- Author(s)
  Aida S, Ichikawa D, Iida K, Hozumi M, Nakamura M, Uozaki R, Hashimoto N, Okayama M, Yonemura Y, Tabata N, Yamada T, Matsushita M, Sugai T, Yanagawa H, Hattori Y.
- Organizer
  2017 Annual meeting of American Association for Cancer Research
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] Evaluation of a novel therapeutic target in hematological malignancies.2017
- Author(s)
  Matsushita M, Yokoe S,Ozawa K, Kanchi S, Ichikawa D, Matsuki E, Mori T, Okamoto S, Hattori Y.
- Organizer
  AACR special conference Tumor Immunology and Immunotherapy
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] PEG(E)-TC11は、CRBN非依存的に細胞周期の調節を介してハイリスク骨髄腫の増殖を抑制する。2017
- Author(s)
  會田宗司, 市川大樹, 中村美沙, 宇於崎涼, 飯田和樹, 穂積暢史, 岡山幹夫, 藤森宏太, 米村裕子, 田畠典子, 山田健人, 松下麻衣子, 須貝威, 柳川弘志, 服部豊
- Organizer
  第42回日本骨髄腫学会学術集会
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] 天然物由来の新規コマロビキノン誘導体はP53欠損多発性骨髄腫を克服する2017
- Author(s)
  藤森剛太、岡山幹夫、市川大樹、松下麻衣子、服部豊
- Organizer
  第76回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] Establishment of KU-MEL9-specific cytotoxic T cells for the development of adoptive immunotherapy for multiple myeloma.2017
- Author(s)
  Yokoe S, Matsushita M, Ozawa K, Uchiumi A, Kashiwazaki S, Ichikawa D, Hattori Y.
- Organizer
  The 8th International Symposium2017 by Japanese Society of Hematology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] Cereblon-independent anti-myeloma pathway of TC11, a novel compound of immunomodulatory drugs.2017
- Author(s)
  Nakamura M, Ichikawa D, Aida S, Hashimoto N, Murota W, Uozaki R, Okayama M, Fujimori K, Yonemura Y, Noriko Tabata N, Yanagawa H, Matsushita M, Hattori Y.
- Organizer
  79th Annual Meeting Japanese Society of Hematology
- Data Source
  KAKENHI-PROJECT-17K09940
[Presentation] Immunogenicity of Novel Antigen Expressed in Leukemia Stem Cells.2016
- Author(s)
  Ozawa K, Matsushita M, Yokoe S, Kanchi S, Uchiumi A, Ichikawa D, Matsuki E, Sakurai M, Karigane D, Kasahara H, Kawakami Y, Okamoto S, Hattori Y.
- Organizer
  The 5thJCA-AACR Joint Conference
- Place of Presentation
  東京ベイ舞浜ホテル（千葉県浦安市）
- Year and Date
  2016-07-13
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461453
[Presentation] Komaroviquinone-derivatives, revealed anti-tumor effect on high-risk multiple myeloma cells in vitro as well as in vivo.2016
- Author(s)
  Sato M, Kitabatake S, Ichikawa D, Suto Y, Iwasaki G, Kiuchi F, Yamaguchi T, Ueda A, Aida S, Matsushita M, & Hattori Y.
- Organizer
  58th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition.
- Place of Presentation
  San Diego Convention Center, San Diego, CA., USA
- Year and Date
  2016-12-03
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461432
[Presentation] Novel Komaroviquinone derivatives with anti-protozoal activity inhibited growth of high-risk myeloma cells in vivo.2016
- Author(s)
  Yamaguchi T, Ichikawa D, Ueda A, Aida S, Matsushita M, Hattori Y.
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（神奈川県、横浜市）
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-26461432
[Presentation] Clinical significance of 11;14 translocation in myeloma, AL amyloidosis and mantle cell lymphoma.2015
- Author(s)
  Kasuga M, Ikeda M, Shingaki S, Miyazaki K, Meshituka S, Yoshiki Y, Abe Y, Tsukada N, Hattori Y, Suzuki K.
- Organizer
  第77回日本血液学会
- Place of Presentation
  石川県立音楽堂（石川県・金沢市）
- Year and Date
  2015-10-17
- Data Source
  KAKENHI-PROJECT-26461432
[Presentation] Identification of New IMiDs-Binding Proteins and Nonteratogenic Drug Design for High-Risk Myeloma.2015
- Author(s)
  Hozumi M, Matsushita M, Ichikawa D, Ozaki Y, Hasegawa Y, Terada F, Yanagawa H, Tabata N, Shiheido H, Oikawa T, Matsuo K, Yamada T, Wenlin Du W, Kitabatake S, Ueda A, Hattori Y.
- Organizer
  第77回日本血液学会
- Place of Presentation
  石川県立音楽堂（石川県・金沢市）
- Year and Date
  2015-10-16
- Data Source
  KAKENHI-PROJECT-26461432
[Presentation] Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI2015
- Author(s)
  Matsushita M, Koji Ozawa, Kanchi S, Uchiumi A, Suzuki T, Ichikawa D, Matsuski E, Sakurai M, Karigane D, Nakajima H, Okamoto S, Hattori Y.
- Organizer
  30th Annual Meeting of The Society for Immunotherapy of Cancer（SITC）
- Place of Presentation
  メリーランド州ナショナルハーバー（アメリカ合衆国）
- Year and Date
  2015-11-04
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461453
[Presentation] イマチニブ投与中止後CML患者におけるがん幹細胞抗原特異的CTLの解析2015
- Author(s)
  神地沙織、小澤光司、松下麻衣子、松木絵里、櫻井政寿、雁金大樹、市川大樹、岡本真一郎、服部豊
- Organizer
  第７回血液疾患免疫療法研究会学術集会
- Place of Presentation
  東京大学国際学術研究センター内　伊藤謝恩ホール（東京都文京区）
- Year and Date
  2015-09-26
- Data Source
  KAKENHI-PROJECT-26461453
[Presentation] ハイリスク多発性骨髄腫に対する新規治療薬の開発.2015
- Author(s)
  北畠翔太朗、松下麻衣子、市川大樹、尾崎由枝、長谷川由佳、寺田蕗子、柳川弘志、田畠典子、始平堂弘和、及川司、松尾光一、山田健人、杜雯林、穂積暢史、植田有美、服部豊
- Organizer
  第16回 Pharmaco-Hematologyシンポジウム（日本薬学会生物系薬学部会）
- Place of Presentation
  日本薬学会長井記念館（東京）
- Year and Date
  2015-06-13
- Data Source
  KAKENHI-PROJECT-26461432
[Presentation] 白血病幹細胞に発現する新規がん精巣抗原の同定2015
- Author(s)
  小澤光司、松下麻衣子、中村美紀、鈴木拓真、市川大樹、塚本信夫、河上裕、服部豊
- Organizer
  第12回日本免疫治療学研究会学術集会
- Place of Presentation
  東京都　東京ガーデンパレス
- Year and Date
  2015-02-28
- Data Source
  KAKENHI-PROJECT-26461453
[Presentation] Drug Design for Overcoming High-Risk Myeloma and Identification of Novel Binding Proteins to Immune-Modulatory Drugs.2015
- Author(s)
  Hozumi M, Ichikawa D, Matsushita M, Kamiyama E, Yanagawa H, Tabata N, Kitabatake S, Ueda A, Yamaguchi T, Sato M, Hattori Y.
- Organizer
  57th AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition.
- Place of Presentation
  Orlando, FL. (USA)
- Year and Date
  2015-12-05
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26461432
[Presentation] MタンパクL鎖に結合した糖鎖構造に基づく多発性骨髄腫の病態解析2013
- Author(s)
  飯島史朗, 松下麻衣子, 服部豊.
- Organizer
  第64回日本電気泳動学会総会
- Place of Presentation
  仙台
- Data Source
  KAKENHI-PROJECT-24590209
[Presentation] Mタンパク糖鎖構造に着目した多発陛骨髄腫における骨融解病変検出マーカーの開発2012
- Author(s)
  小高香澄, 他6名中服部豊は7番目
- Organizer
  日本薬学会第132年会
- Place of Presentation
  北海道大学
- Year and Date
  2012-03-30
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] M蛋白糖鎖のレクチンブロットおよび質量分析を用いた構造解析2012
- Author(s)
  川村真理恵, 他6名中服部豊は7番目
- Organizer
  日本薬学会第132年会
- Place of Presentation
  北海道大学
- Year and Date
  2012-03-30
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 難治性造血器腫瘍治療の現状と問題点。検査・バイオマーカーといった分析学は、治療法の発展にどのような貢献をしているか2011
- Author(s)
  服部豊
- Organizer
  日本分析化学会第60年会
- Place of Presentation
  名古屋大学
- Year and Date
  2011-09-16
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 新規フタルイミド誘導体の抗骨髄腫作用の検討2011
- Author(s)
  寺田蕗子、尾崎由枝、内藤悠平, 鈴木裕也, 柳川弘志, 始平堂弘和、田原佳代子、山田健人, 杜ぶん林, 飯島史朗, 松下麻衣子, 服部豊
- Organizer
  第131回日本薬学会年会
- Place of Presentation
  静岡
- Year and Date
  2011-03-29
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 難治性造血器腫瘍治療の現状と問題点。検査・バイオマーカーといった分析学は、治療法の発展にどのような貢献をしているか2011
- Author(s)
  服部豊
- Organizer
  日本分析化学会第60年会
- Place of Presentation
  名古屋大学(招待講演)
- Year and Date
  2011-09-16
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] Phase 2 study of post-transplant thalidomide consolidation therapy for multiple myeloma2011
- Author(s)
  上田智基, 服部豊
- Organizer
  第73回日本血液学会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2011-10-14
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] A Novel Anilinoqunazoline Derivative Inhibits Growth of High-Risk Myeloma Cells In Vivo and Regulates Differentiation of Osteoclasts2010
- Author(s)
  Ozaki Y, Naito Y, Yanagawa H, Suzuki Y, Du W, Yamada T, Matsuo K, Doi N, Iijima S, Matsushita M, Tahara K, Hattori Y
- Organizer
  52nd AMERICAN SOCIETY of HEMATOLOGY Annual Meeting and Exposition
- Place of Presentation
  Orland, FL. Blood
- Year and Date
  2010-12-06
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] A novel anilinoqunazoline derivative inhibits growth of high-risk myeloma cells in vivo and regulates differentiation of osteoclasts.2010
- Author(s)
  Ozaki Y, ほか11名Hattori Y(corr esponding author)は11番目
- Organizer
  52nd American Society of Hematology annual meeting & exposition
- Place of Presentation
  Orland, USA
- Year and Date
  2010-12-06
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 新規アニリノキナゾリン誘導体を用いたin vivoにおけるハイリスク多発性骨髄腫の治療効果2010
- Author(s)
  内藤悠平, 鈴木裕也, 尾崎由枝, 柳川弘志, 杜ぶん林, 山田健人, 土居信英, 飯島史朗, 松下麻衣子, 田原佳代子, 服部豊
- Organizer
  第69回日本癌学会学術総合大会
- Place of Presentation
  大阪市
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 血管新生増殖因子(FGF・HGF)をターゲットとしたハイリスク多発性骨髄腫の分子標的療法の確立2010
- Author(s)
  星真理子, ほか10名服部豊(corresponding author)は10番目
- Organizer
  第11回Pharmaco-Hematologyシンポジウム
- Place of Presentation
  東京
- Year and Date
  2010-06-18
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 多発性骨髄腫の初期治療、海外からの報告の総括とわが国の現状2010
- Author(s)
  服部豊
- Organizer
  第72回日本血液学会総会
- Place of Presentation
  横浜(教育講演)
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 血管新生増殖因子(FGF・HGF)をターゲットとしたハイリスク多発性骨髄腫の分子標的療法の確立2010
- Author(s)
  星真理子, 寺田蕗子, 尾崎由枝1, 鈴木裕也, 内藤悠平, 松本邦夫, 杜ぶん林, 山田健人, 飯島史朗, 松下麻衣子, 服部豊
- Organizer
  第11回日本薬学会Pharmaco-Hematologyシンポジウム
- Place of Presentation
  東京都
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 教育講演「多発性骨髄腫の初期治療、海外からの報告の総括とわが国の現状」2010
- Author(s)
  服部豊
- Organizer
  第72回日本血液学会総会
- Place of Presentation
  横浜
- Year and Date
  2010-09-25
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] ハイリスク骨髄腫克服のためのスクリーニングシステムの構築2010
- Author(s)
  鈴木裕也, 寺田蕗子, 内藤悠平, 柳川弘志, 杜ぶん林, 山田健人, 土居信英, 飯島史朗, 松下麻衣子, 田原佳代子, 服部豊
- Organizer
  第54会日本薬学会関東支部大会
- Place of Presentation
  東京
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 多発性骨髄腫治療の現状と問題点2009
- Author(s)
  服部豊
- Organizer
  第53回日本薬学会関東支部大会
- Place of Presentation
  埼玉県坂戸市
- Year and Date
  2009-10-03
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] 多発性骨髄腫治療の現状と問題点2009
- Author(s)
  服部豊
- Organizer
  第53回日本薬学会関東支部大会
- Place of Presentation
  城西大学坂戸市
- Year and Date
  2009-10-03
- Data Source
  KAKENHI-PROJECT-21591221
[Presentation] Identification of novel cancer-testis antigen expressed in leukemic stem cells of chronic myelogenous leukemia.
- Author(s)
  Matsushita M, Nakamura M, Ichikawa D, Tsukamoto N, Kawakami Y, Hattori Y.
- Organizer
  ISEH 43rd Annual Scientific Meeting
- Place of Presentation
  カナダ　モントリオール
- Year and Date
  2014-08-21 – 2014-08-24
- Data Source
  KAKENHI-PROJECT-26461453

1. YAMADA Taketo (60230463)

# of Collaborated Projects: 5 results

# of Collaborated Products: 18 results
2. Matsushita Maiko (10327520)

# of Collaborated Projects: 3 results

# of Collaborated Products: 12 results
3. KIZAKI Masahiro (20161432)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. IKEDA Yasuo (00110883)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
5. KAMATA Tamihiro (90265794)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
6. YANAGAWA Hiroshi (40327672)

# of Collaborated Projects: 2 results

# of Collaborated Products: 9 results
7. 木内文之 (60161402)

# of Collaborated Projects: 2 results

# of Collaborated Products: 5 results
8. 河上裕 (50161287)

# of Collaborated Projects: 2 results

# of Collaborated Products: 6 results
9. IIJIMA Shiro (30222798)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
10. 長田重一 (70114428)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 藤沢淳子 (60209038)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. 仙波憲太郎 (70206663)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
13. 畠山昌則 (40189551)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
14. 審良静男 (50192919)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
15. 武藤章弘 (90239468)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
16. 須貝威 (60171120)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
17. NAGASE Kenichi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
18. 黒田雅彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
19. 中島秀明

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Hattori Yutaka 服部 豊

HATTORI Yutaka 服部 豊

服部 豊 ハツトリ ユタカ

Research Projects

Research Products

Co-Researchers

Why multiple myeloma is incurable?Exploitation of molecular pathogenesis and development of overcoming drug by targeting autophagyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Exploitation of molecular mechanisms and development of overcoming drugs from new perspectives for high-risk myeloma with poor prognosisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of novel combined immunotherapy using in silico screening system

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

molecular analysis and drug discovery targeting extramedullary disease in high-risk multiple myelomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Drug discovery based on novel concept for overcoming high-risk myeloma which is still intractable despite of recent progress in the treatmentPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Development of novel immunotherapy targeting leukemic stem cells.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

M-protein binding oligosaccharides as a candidate of biomarker for multiple myeloma

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Analysis on molecular mechanism of anti-tumor effect of thalidomide and exploitation of novel agents to overcome therapy-resistant multiple myelomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Establishment of Novel Method for Hematopoietic Stem Cell Transplantation Using Thioredoxin-Gene Transfer TechniquePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

脂溶性リガンドによる造血調節:新たな体外増幅を目指して

Principal Investigator

Project Period (FY)

Research Category

Research Institution

がんの増殖と分化に関連する遺伝子の発現制御

Principal Investigator

Project Period (FY)

Research Category

Research Institution

[Book] 薬剤師のための症候学 第2版第6刷2023

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] GTN057, a komaroviquinone derivative, induced myeloma cells' death in vivo and inhibited c-MET tyrosine kinase.2023

Author(s)

Journal Title

DOI

Hattori Yutaka 服部豊

HATTORI Yutaka 服部豊

服部豊ハツトリユタカ

[Book] 薬剤師のための症候学　第2版第6刷2023

[Journal Article] 分子標的療法サリドマイド　多発性骨髄腫学2016